Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To compare the efficacy and safety of rho kinase inhibitors to placebo or other glaucoma medication in people diagnosed with open-angle glaucoma or ocular hypertension.
Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension / Clement Freiberg J.; von Spreckelsen A.; Khachatryan N.; Kolko M.; Azuara-Blanco A.; Virgili G.. - In: COCHRANE LIBRARY. - ISSN 1465-1858. - ELETTRONICO. - 2020:(2020), pp. CD013817.0-CD013817.0. [10.1002/14651858.CD013817]
Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension
Virgili G.Writing – Review & Editing
2020
Abstract
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To compare the efficacy and safety of rho kinase inhibitors to placebo or other glaucoma medication in people diagnosed with open-angle glaucoma or ocular hypertension.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
